四環醫藥(00460.HK)治療休克綜合症藥物獲內地藥品註冊批件

You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.

Hong Kong

Open Account

四環醫藥(00460.HK)治療休克綜合症藥物獲內地藥品註冊批件

阿思達克 07-06 12:11

四環醫藥(00460.HK)公布，附屬吉林振澳研發的用於治療休克綜合症藥物鹽酸多巴胺注射液(規格：2.5ml：50mg；5ml：100mg)獲得國家藥監局頒發的藥品註冊批件，視同通過仿製藥質量和療效一致性評價。

四環醫藥(00460.HK)

Relevant Stocks

四環醫藥(00460.HK)

Customer Service Hotline︰+852 3018 4526

Email︰cs@usmarthk.com

Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong

WhatsApp︰+852 5989 2641

Join the Community：

uSmart Securities Limited

is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Market News

四環醫藥(00460.HK)治療休克綜合症藥物獲內地藥品註冊批件

Services

About Us

Agreement Statement